Literature DB >> 23372021

Roles of chemokine ligand-2 (CXCL2) and neutrophils in influencing endothelial cell function and inflammation of human adipose tissue.

Christine Rouault1, Vanessa Pellegrinelli, Raphaela Schilch, Aurélie Cotillard, Christine Poitou, Joan Tordjman, Henrike Sell, Karine Clément, Danièle Lacasa.   

Abstract

The hypertrophied white adipose tissue (WAT) during human obesity produces inflammatory mediators, including cytokines (IL-6 and TNFα) and chemokines ([C-C motif] chemokine ligand 2 and IL-8). These inflammatory factors are preferentially produced by the nonadipose cells, particularly the adipose tissue infiltrating macrophages. We identified the chemokine (C-X-C motif) ligand 2 (CXCL2) by a transcriptomic approach. Because CXCL2 could represent a WAT-produced chemokine, we explored its role in obesity-associated inflammation. CXCL2 levels in serum and mRNA in WAT were higher in obese subjects compared with lean ones. CXCL2 secretions were higher in sc and visceral (vis) WAT from obese compared with lean subjects. In vis WAT, CXCL2 mRNA expression was higher in macrophages compared with other WAT cells and positively correlated with the inflammatory macrophage markers TNFα and IL-6. CXCL2 triggered the in vitro adhesion of the neutrophils, its selective cell targets, to endothelial cells (ECs) of vis WAT (vis WAT-ECs). Immunohistological analysis indicated that activated neutrophils were adherent to the endothelium of vis WAT from human obese subjects. Blood neutrophils from obese subjects released high levels of proinflammatory mediators (IL-8, chemokine motif ligand 2 [CCL2], matrix metalloproteinase [MMP] 9, and myeloperoxidase [MPO]). Visceral WAT-ECs, treated by neutrophil-conditioned media prepared from obese subjects, displayed an increase of the expression of inflammatory molecules associated with senescence and angiogenic capacities. To conclude, CXCL2, a WAT-produced chemokine being up-regulated in obesity, stimulates neutrophil adhesion to vis WAT-ECs. Activated neutrophils in obesity may influence vis WAT-ECs functions and contribute to WAT inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23372021     DOI: 10.1210/en.2012-1415

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  46 in total

1.  Grape seed procyanidin supplementation to rats fed a high-fat diet during pregnancy and lactation increases the body fat content and modulates the inflammatory response and the adipose tissue metabolism of the male offspring in youth.

Authors:  J M del Bas; A Crescenti; A Arola-Arnal; G Oms-Oliu; L Arola; A Caimari
Journal:  Int J Obes (Lond)       Date:  2014-08-25       Impact factor: 5.095

2.  Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.

Authors:  Elise Dalmas; Amine Toubal; Fawaz Alzaid; Katrina Blazek; Hayley L Eames; Kristell Lebozec; Maria Pini; Isabelle Hainault; Emilie Montastier; Raphaël G P Denis; Patricia Ancel; Amélie Lacombe; Yin Ling; Omran Allatif; Céline Cruciani-Guglielmacci; Sébastien André; Nathalie Viguerie; Christine Poitou; Vladimir Stich; Alexandra Torcivia; Fabienne Foufelle; Serge Luquet; Judith Aron-Wisnewsky; Dominique Langin; Karine Clément; Irina A Udalova; Nicolas Venteclef
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

Review 3.  The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.

Authors:  Clair Crewe; Yu Aaron An; Philipp E Scherer
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 4.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

5.  Obesity Modulates Inflammation and Lipid Metabolism Oocyte Gene Expression: A Single-Cell Transcriptome Perspective.

Authors:  Meghan L Ruebel; Matthew Cotter; Clark R Sims; Dean M Moutos; Thomas M Badger; Mario A Cleves; Kartik Shankar; Aline Andres
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

6.  Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.

Authors:  Elif A Oral; Shannon M Reilly; Andrew V Gomez; Rasimcan Meral; Laura Butz; Nevin Ajluni; Thomas L Chenevert; Evgenia Korytnaya; Adam H Neidert; Rita Hench; Diana Rus; Jeffrey F Horowitz; BreAnne Poirier; Peng Zhao; Kim Lehmann; Mohit Jain; Ruth Yu; Christopher Liddle; Maryam Ahmadian; Michael Downes; Ronald M Evans; Alan R Saltiel
Journal:  Cell Metab       Date:  2017-07-05       Impact factor: 27.287

7.  The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.

Authors:  Zhuo-Teng Yu; N Nanda Nanthakumar; David S Newburg
Journal:  J Nutr       Date:  2016-09-14       Impact factor: 4.798

8.  Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis.

Authors:  Stella Aslibekyan; Jin Sha; David T Redden; Larry W Moreland; James R O'Dell; Jeffrey R Curtis; Ted R Mikuls; Richard J Reynolds; Maria I Danila; S Louis Bridges
Journal:  Ann Rheum Dis       Date:  2013-11-29       Impact factor: 19.103

Review 9.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 10.  Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease.

Authors:  Zoi Michailidou; Mario Gomez-Salazar; Vasileia Ismini Alexaki
Journal:  J Innate Immun       Date:  2021-04-13       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.